Brass Mesh Bolus in Rotational Post-Mastectomy Radiation Therapy
A Clinical Trial to Assess Skin Dose in Post-mastectomy Adjuvant Radiation Therapy of Breast Cancer Patients Using a Brass Mesh Bolus
Nova Scotia Cancer Centre
20 participants
Jan 18, 2023
INTERVENTIONAL
Conditions
Summary
The hypothesis is that the daily use of brass mesh bolus achieves a comparable dose to every-other-day use of Superflab bolus (current standard of care) in chest wall post-mastectomy patients treated with rotational 6 MV photon delivery.
Eligibility
Inclusion Criteria1
- Women undergoing rotational chest wall radiotherapy following mastectomy for breast cancer treatment who would utilize Superflab bolus on some, but not all, days of radiotherapy treatment.
Exclusion Criteria1
- Patients who require daily bolus due to skin involvement or other high-risk features requiring a high skin dose will not be included.
Interventions
During a standard-of-care 15 fraction radiotherapy treatment, a brass mesh bolus will be used for a single fraction. Small in-vivo dosimeters will be used for three treatment fractions to measure and compare skin doses for quantification purposes.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05483712